Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France
曲妥珠单抗德鲁替康用于既往接受过治疗的HER2阳性转移性或不可切除乳腺癌：来自法国临时使用授权项目的真实世界数据
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.7168
Petit, Thierry; Hajjaji, Nawale; Antoine, Eric-Charles; Benderra, Marc-Antoine; Gozy, Michel; Foa, Cyril; Mouysset, Jean-Loup; Grenier, Julien; Mousseau, Mireille; Mailliez, Audrey; Saghatchian, Mahasti; Lachaier, Emma; Desmoulins, Isabelle; Hennequin, Audrey; Maes, Patricia; Loirat, Delphine; Ricci, Francesco; Diéras, Véronique; Berton, Dominique; Tiong, Florence Lai; Teixeira, Luis; Dohollou, Nadine; Lévy, Christelle; Bachelot, Thomas; Pierga, Jean-Yves
